IRIS
QUERCIOLI, ALESSANDRA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.141
SA - Sud America 14
AS - Asia 13
NA - Nord America 1
Totale 7.169
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.141
BR - Brasile 13
CN - Cina 6
VN - Vietnam 6
CO - Colombia 1
ID - Indonesia 1
NI - Nicaragua 1
Totale 7.169
Salva come PNG Salva come JPEG
Città #
Genova 4.688
Genoa 1.598
Vado Ligure 445
Rapallo 396
Bordighera 14
Beijing 2
Belo Horizonte 2
Ho Chi Minh City 2
Ananindeua 1
Araraquara 1
Bandung 1
Bertioga 1
Bogotá 1
Buon Ma Thuot 1
Campos dos Goytacazes 1
Capim Branco 1
Coruripe 1
Goianira 1
Haiphong 1
Hanoi 1
Magé 1
Managua 1
Natal 1
Sumaré 1
São Paulo 1
Totale 7.164
Salva come PNG Salva come JPEG
Nome #
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 205
The vulnerable coronary plaque: update on imaging technologies. 198
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. 197
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 182
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. 175
Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity. 167
Impact of obesity and bariatric surgery on metabolism and coronary circulatory function. 165
Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. 165
Anti-apolipoprotein a-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals. 161
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 161
Clorhexidine prevents hypoclorous acid-induced inactivation of alpha1-antitrypsin. 158
Statins in the treatment of acute ischemic stroke. 157
Inflammation in the pathophysiology of essential hypertension. 154
New evidence for nicotinic acid treatment to reduce atherosclerosis. 152
Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease. 151
Update on the treatments of non-alcoholic fatty liver disease (NAFLD). 149
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. 144
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). 144
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury 139
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function 138
Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. 137
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 132
Intestinal radiation-induced stricture favours small bowel obstruction by phytobezoar: report of a case 132
Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways. 132
The need of identifying circulating biomarkers of coronary dysfunction 129
Heart failure and chronic kidney disease in a registry of internal medicine wards 125
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. 123
Quantitative PET/CT measures of myocardial flow reserve and atherosclerosis for cardiac risk assessment and predicting adverse patient outcomes. 122
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. 120
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 120
Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT. 120
Improvement in Coronary Endothelial Function is Independently Associated with a Slowed Progression of Coronary Artery Calcification in Type 2 Diabetes Mellitus. 117
Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CT. 116
RANKL/OPG pathway is a promising target to reduce atherosclerosis plaque calcification. 115
Ezetimibe/simvastatin. 115
Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. 115
The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow. 113
A Genetic Polymorphism in the Pannexin1 Gene Predisposes for The Development of Endothelial Dysfunction with Increasing BMI 113
Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight. 112
Effect of NH3 metabolite correction on the myocardial blood flow measurement. 111
Quantitative assessment of myocardial blood flow--clinical and research applications. 110
Role of neutrophils in acute myocardial infarction. 108
Left ventricular dyssynchrony assessment by phase analysis from gated myocardial perfusion SPECT: moving beyond conventional criteria. 104
Plasma concentrations of edocannabinoid are associated with dysfunction of the coronary microcirculation in obese subjects. 99
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 99
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 99
Inter and intra operator variability of myocardial blood flow quantification using dynamic NH3 and Rb PET. 97
Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects 96
Receptor activator of NF-kappa B ligand (RANKL) increases neutrophilic degranulation and potentially associated cardiovascular risk. 90
PET-Determined Hyperemic Longitudinal, Myocardial Flow Gradient as Noninvasive Probe of Epicardial Vasomotion in Cardiovascular Risk Individuals with or Without Coronary Artery Calcifications. 90
Inferior vena cava parameters predict readmission in ischemic heart failure. 88
New evidences for a direct involvement of neutrophils in atherosclerosis. 82
Statin Treatment Is Associated with Reduction in Serum Levels of Receptor Activator of NF-kappaB Ligand and Neutrophil Activation in Patients with Severe Carotid Stenosis. 82
Effect of gastric bypass on vasomotor function of the coronary circulation in morbid obese individuals without cardiovascular diseases. 79
Sulphasalazin accelerates apoptosis in neutrophils exposed to immune complex: role of caspase pathway. 76
Novel treatment strategy with direct renin inhibition against heart failure. 75
Mechanisms underlying endothelial dysfunction in obstructive sleep apnea syndrome (OSAS) patients. 59
Plasma palmitoylethanolamide as potential predictor of coronary dysfunction. 55
Totale 7.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.373
article - articoli 21.566
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 807
Totale 44.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 0 0 0 57 18 45 5 62 33 55 26 48
2021/2022736 37 74 26 89 54 50 61 160 20 58 29 78
2022/2023518 77 42 8 30 61 93 1 34 79 2 80 11
2023/2024293 10 46 8 41 21 75 16 18 15 5 7 31
2024/20251.029 19 70 24 51 196 128 135 135 44 37 81 109
2025/2026641 197 67 177 200 0 0 0 0 0 0 0 0
Totale 7.269